Results 1 to 10 of about 634,016 (348)

Neuroendocrine neoplasms of the esophagus and stomach [PDF]

open access: goldPathologica, 2021
Summary Esophageal neuroendocrine neoplasms (E-NENs) are much rarer than other gastro-entero-pancreatic neuroendocrine neoplasms, the majority showing aggressive behavior with early dissemination and poor prognosis.
Luca Mastracci   +8 more
semanticscholar   +6 more sources

Respiratory muscle strength of patients with esophagus and stomach neoplasms [PDF]

open access: goldFisioterapia em Movimento, 2017
Introduction: In cancer patients, the reduced food intake causes weight loss and promotes protein-calorie malnutrition. This results in loss of lean body mass, which affects both skeletal muscles and respiratory muscles.
Evelyn Aline Boscolo Ruivo   +4 more
doaj   +3 more sources

The Synchronous Prevalence of Colorectal Neoplasms in Patients with Stomach Cancer [PDF]

open access: hybridJournal of the Korean society of coloproctology, 2011
Purpose The association between stomach cancer and colorectal cancer is controversial. The purpose of this study was to determine the synchronous prevalence of colorectal neoplasms in patients with stomach cancer.
Ryung‐Ah Lee
semanticscholar   +4 more sources

Endoscopic submucosal dissection for stomach neoplasms

open access: hybridWorld Journal of Gastroenterology, 2006
Recent advances in techniques of therapeutic endoscopy for stomach neoplasms are rapidly achieved. One of the major topics in this field is endoscopic submucosal dissection (ESD).
Mitsuhiro Fujishiro
semanticscholar   +3 more sources

The role of endoscopic ultrasound investigation in the diagnosis of submucosal neoplasms of the stomach and duodenum (literature review and our clinical observations)

open access: diamondGastroenterologìa, 2021
Submucosal neoplasms of the stomach and duodenum include a group of diseases with different etiology, clinical symptoms, diagnosis and management. Conventional gastroduodenoscopy helps detect submucosal formations in 0.36–4 % of cases, while the stomach ...
Yu.M. Stepanov   +5 more
doaj   +3 more sources

Neuroendocrine neoplasms of the stomach [PDF]

open access: goldBiomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2013
BACKGROUND Gastric neuroendocrine neoplasms of type 1 and type 3 are different entities and as such require different therapeutical strategies. The aim of this study was to define and distinguish these two tumour subtypes with clearly different ...
O Louthan
openalex   +2 more sources

The problem of verification of malignant neoplasms of the stomach in surgical practice

open access: diamondВестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, 2022
Relevance. Despite numerous efforts made in recent decades, the arsenal of cancer diagnostics is still significantly limited. The purpose of study: to analyze the problem of differential diagnosis of early stage stomach cancer and non-oncological ...
D. A. Maksimov   +4 more
doaj   +3 more sources

Metachronous Multiple Primary Malignant Neoplasms of the Stomach and the Breast: Report of Two Cases With Review of Literature [PDF]

open access: bronzeInternational surgery, 2014
Multiple primary malignant neoplasm is the occurrence of a second primary malignancy in the same patient within 6 months of the detection of first primary (synchronous), or 6 months or more after primary detection (metachronous).
Vilvapathy Senguttuvan Karthikeyan   +6 more
openalex   +2 more sources

Lipid is absorbed in the stomach by epithelial neoplasms (adenomas and early cancers): a novel functional endoscopy technique [PDF]

open access: goldEndoscopy International Open, 2015
Background and study aims: The authors have successfully demonstrated that the white opaque substance (WOS) identified in gastric epithelial neoplasms is an accumulation of minute lipid droplets on the epithelial neoplasm.
Kensei Ohtsu   +17 more
openalex   +2 more sources

Expression of Cystatin C in human stomach neoplasms

open access: bronzeMolecular Medicine Reports, 2010
Cystatin C is a member of the cysteine protease inhibitor family and functions to decrease protease production. A recent study showed that it is aberrantly expressed in many malignant tumors in association with tumor invasion and metastasis.
Li Li
openalex   +3 more sources

Home - About - Disclaimer - Privacy